Actively Recruiting
Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up
Led by Lifetech Scientific (Shenzhen) Co., Ltd. · Updated on 2025-01-08
145
Participants Needed
7
Research Sites
177 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.
CONDITIONS
Official Title
Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a confirmed diagnosis of Atrial Septal Defect (ASD) and implanted with the investigational device as per IFU instructions.
- Patients or legally authorized representatives have signed Data Release Consent or equivalent documents.
You will not qualify if you...
- Patients did not conduct any follow up visit after hospital discharge.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Hospital Pequeno Príncipe
Curitiba, Brazil
Not Yet Recruiting
2
Universidade Federal do Ceará
Fortaleza, Brazil
Not Yet Recruiting
3
Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Brazil
Not Yet Recruiting
4
HCOR - Associação Beneficente Síria
São Paulo, Brazil
Not Yet Recruiting
5
Hospital Beneficência Portuguesa
São Paulo, Brazil
Not Yet Recruiting
6
Onassis Cardiac Surgery Center
Kallithea, Greece
Actively Recruiting
7
IRCCS Policlinico San Donato
Milan, Italy
Actively Recruiting
Research Team
R
Rae Gong, PM
CONTACT
K
KaDirr Shemsi, APM
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here